55
Participants
Start Date
August 31, 2005
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
AMG 531
"Beginning with Cycle 2, administered in one of two schedules, either on day after chemotherapy and 2 days later (study cycle) or on day -5 (pre dose) and on day after chemotherapy (post dose) or combination of pre/post days of 21-28 day treatment cycle. Combination if Optimal biological dose (OBD) not reached, additional treatment at 10 mcg/kg dose level, with AMG 531 administered on day -5 (pre dose) and on day after chemotherapy (post dose).~1, 3, or 10 mcg/kg given as injection under the skin (subcutaneous)"
Carboplatin
AUC=11; Cycle 1 chemotherapy alone then 3 weeks later, in Cycle 2, same dose of chemotherapy followed by AMG 531.
Adriamycin
75-90 mg/m\^2 IV
Ifosfamide
10 gm/m\^2 IV; OR, High dose ifosfamide = 14 gm/m\^2.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Amgen
INDUSTRY
M.D. Anderson Cancer Center
OTHER